Meconia 2500 Injection
ampoule of 2.0 ml Injection.Prescription required
About this product:
| Salt Composition: | Methylcobalamin (2500mcg) |
| Manufacturer: | Geneva Biocare |
| Storage: | Below 25 degree celcius |
Out of Stock
Have doubts about this medicine?
Have doubts about this medicine?
Meconia 2500 Injection is a man-made form of vitamin B12 used to treat deficiency of vitamin B12 in the body. Meconia 2500 Injection is a form of vitamin B12 that restores its level in the body thereby helping in treating certain anemias and nerve problems. It is used to treat deficiency of vitamin B12 in the body. Vitamin B12 is important for growth, cell reproduction, blood formation, and protein and tissue synthesis. It also helps to treat anemia, fatigue, and numbness or tingling in the hands and feet.
Meconia 2500 Injection is a form of vitamin B12 that restores its level in the body thereby helping in treating certain anemias and nerve problems.
What is Meconia 2500 Injection?
Meconia 2500 Injection is a solution containing vitamin B12. Vitamin B12 plays an essential role in producing red blood cells and supporting a healthy nervous system. It also helps release energy from food and utilize vitamin B11 (folic acid).
Why might I not be getting enough vitamin B12 from my diet?
Vitamin B12 can be obtained from sources like meat, fish, eggs, and dairy products. However, people who follow a vegetarian or vegan diet may struggle to get Vitamin B12 as it is not naturally found in common fruits, vegetables, and grains. Therefore, individuals following these diets are more likely to develop vitamin B12 deficiency.
What happens if I have a vitamin B12 deficiency?
Deficiency of vitamin B12 can lead to symptoms such as fatigue and weakness, constipation, loss of appetite, weight loss, and megaloblastic anemia (an enlarged red blood cell condition). It may also cause nerve problems like numbness and tingling in the hands and feet. Other potential symptoms include balance difficulties, depression, confusion, dementia, memory impairment, dry mouth, or tongue soreness.
Is Meconia 2500 Injection safe?
Meconia 2500 Injection is generally well-tolerated and considered safe. However, some individuals may experience rare side effects such as nausea, diarrhea, anorexia, or skin rash. If you notice a rash while taking this medicine, discontinue its use immediately.
How should Meconia 2500 Injection be administered?
Meconia 2500 Injection can be given either directly into a vein (intravenously) or muscle (intramuscularly). The usual dose is one ampoule of 0.5mg of Meconia 2500 Injection, administered three times a week. After two months, one ampoule (0.5 mg of Meconia 2500 Injection) may be given every one to three months as part of maintenance therapy.
What precautions should I take when administering Meconia 2500 Injection?
Always inject the medication at different sites each time. If you experience intense pain or feel blood returning to the syringe, remove the needle and re-insert at a different location.
Your doctor or nurse will give you this medicine. Kindly do not self administer.
- Meconia 2500 Injection helps replenish vitamin B12 level in your body.
- This further helps in regeneration of damaged nerves in the body.
- Meconia 2500 Injection helps in treating certain anemias and nerve problems.
- Please avoid or limit alcohol consumption while taking this medication.
- Please consult your doctor before taking this medication.
- No common side effects listed.
Alcohol
It is not known whether it is safe to consume alcohol with Meconia 2500 Injection. Please consult your doctor.
Breastfeed
Meconia 2500 Injection is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Pregnancy
Meconia 2500 Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
